F-group (family)
141.1.1.2 SQS_PSY
Ligands and drugs
325
Member domains
145
with ligand contacts (≤ 4 Å)
44.6% of members
139
with DrugDomain annotations
42.8% of members
52
with a DrugBank compound
16.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 141.1.1.2 belongs to X-group 141 Terpenoid synthases, which binds 8.7 ligand superclasses per 20 proteins, broader than 72% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04695 | FPS | Farnesyl thiopyrophosphate | 24 |
| DB07420 | B65 | (1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid | 7 |
| DB09459 | TLA | L-tartaric acid | 2 |
| DB14756 | SRT | meso-Tartaric acid | 2 |
| DB01694 | TAR | D-tartaric acid | 1 |
| DB04532 | IND | Indole | 1 |
| DB07424 | B70 | Tripotassium (1R)-4-biphenyl-4-yl-1-phosphonatobutane-1-sulfonate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 40 |
| FPS | S-[(2E,6E)-3,7,11-TRIMETHYLDODECA-2,6,10-TRIENYL] TRIHYDROGEN THIODIPHOSPHATE | 26 |
| 8PH | hydrogen [(1R)-2-(3-decyl-1H-imidazol-3-ium-1-yl)-1-hydroxy-1-phosphonoethyl]phosphonate | 10 |
| E5S | (3R)-3-({2-benzyl-6-[(3R,4S)-3-hydroxy-4-methoxypyrrolidin-1-yl]pyridin-3-yl}ethynyl)-1-azabicyclo[2.2.2]octan-3-ol | 10 |
| ER4 | (3R)-3-{[2-benzyl-6-(3-methoxypropoxy)pyridin-3-yl]ethynyl}-1-azabicyclo[2.2.2]octan-3-ol | 10 |
| RWZ | N-[(2Z)-3,7-dimethylocta-2,6-dien-1-yl]-N'-[(1R,3S,5R,7R)-tricyclo[3.3.1.1~3,7~]dec-2-yl]ethane-1,2-diamine | 9 |
| ZGA | Zaragozic acid A | 8 |
| B65 | (1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid | 7 |
| PS7 | {(1R,2R,3R)-2-[(3E)-4,8-dimethylnona-3,7-dien-1-yl]-2-methyl-3-[(1E,5E)-2,6,10-trimethylundeca-1,5,9-trien-1-yl]cyclopropyl}methyl trihydrogen diphosphate | 7 |
| BH5 | hydrogen [(1R)-1-hydroxy-2-(3-pentadecyl-1H-imidazol-3-ium-1-yl)-1-phosphonoethyl]phosphonate | 6 |
| BH8 | hydrogen [(1S)-2-(3-decyl-1H-imidazol-3-ium-1-yl)-1-phosphonoethyl]phosphonate | 6 |
| BH3 | hydrogen [(1R)-2-(3-pentadecyl-1H-imidazol-3-ium-1-yl)-1-phosphonoethyl]phosphonate | 5 |
| RWY | 2-(4-phenoxyphenoxy)ethyl thiocyanate | 5 |
| 651 | (3R)-3-biphenyl-4-yl-1-azabicyclo[2.2.2]octan-3-ol | 4 |
| AO6 | 2-methyl-1-[(2R)-2-oxidanylpropyl]-9H-carbazole-3,4-dione | 4 |
| IN0 | N-{2-[TRANS-7-CHLORO-1-(2,2-DIMETHYL-PROPYL) -5-NAPHTHALEN-1-YL-2-OXO-1,2,3,5-TETRAHYDRO-BENZO[E][1,4]OXAZEPIN-3-YL]-ACETYL}-ASPARTIC ACID | 3 |
| NImetal | NICKEL (II) ION | 3 |
| POP | PYROPHOSPHATE 2- | 3 |
| 83B | [(3S)-3,7-dimethyloct-6-enyl] phosphono hydrogen phosphate | 2 |
| GGS | phosphonooxy-[(10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]sulfanyl-phosphinic acid | 2 |